Stockscreener 앱 받기
12.49
6.23%
-0.83
전일 마감가:
$13.32
열려 있는:
$13.36
하루 거래량:
416.79K
Relative Volume:
1.01
시가총액:
$321.94M
수익:
-
순이익/손실:
$-52.60M
주가수익비율:
-9.3481
EPS:
-1.3361
순현금흐름:
$-35.80M
1주 성능:
-14.45%
1개월 성능:
-16.82%
6개월 성능:
+76.16%
1년 성능:
+122.24%
1일 변동 폭
$12.47
$13.39
1주일 범위
$12.47
$14.60
52주 변동 폭
$5.335
$18.38
Tenax Therapeutics Inc Stock (TENX) Company Profile
명칭
Tenax Therapeutics Inc
전화
919-855-2100
주소
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Compare TENX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
12.49 | 321.94M | 0 | -52.60M | -35.80M | -1.3361 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-09-08 | 개시 | Piper Sandler | Overweight |
| 2024-10-24 | 개시 | Leerink Partners | Outperform |
| 2024-10-14 | 개시 | Guggenheim | Buy |
| 2024-09-30 | 개시 | William Blair | Outperform |
| 2017-05-18 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2014-12-16 | 개시 | MLV & Co | Buy |
| 2014-11-18 | 개시 | WallachBeth | Buy |
모두보기
Tenax Therapeutics Inc 주식(TENX)의 최신 뉴스
Tenax Therapeutics names Timothy Healey as chief commercial officer By Investing.com - Investing.com Australia
Invus affiliates disclose 2.1% stake in Tenax Therapeutics (TENX) - Stock Titan
Tenax brings in drug launch veteran Timothy Healey to prep TNX-103 - Stock Titan
Tenax Therapeutics, Inc. Appoints Timothy Healey as Chief Commercial Officer, Effective May 4, 2026 - marketscreener.com
Tenax Therapeutics, Inc. (NASDAQ:TENX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Tenax Therapeutics appoints Thomas Staab as chief financial officer - MSN
Tenax wins bullish view at Cantor ahead of pivotal readout - MSN
Tenax Therapeutics (NASDAQ:TENX) Is In A Good Position To Deliver On Growth Plans - Sahm
Discipline and Rules-Based Execution in TENX Response - Stock Traders Daily
How do interest rates affect Tenax Therapeutics (TENX) stock | Q4 2025: Profit Exceeds ViewsSpin Off - Newser
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200 Day Moving AverageHere's What Happened - MarketBeat
Tenax Therapeutics names new CFO - MSN
Tenax Therapeutics names Thomas Staab as chief financial officer By Investing.com - Investing.com India
Tenax Therapeutics (TENX) Stock Movers | Q4 2025: EPS Tops ViewsStock Analysis Community - UBND thành phố Hải Phòng
Companies Like Tenax Therapeutics (NASDAQ:TENX) Are In A Position To Invest In Growth - Yahoo Finance
Tenax Therapeutics Names New CFO to Support Growth - TipRanks
Tenax Therapeutics names Thomas Staab as chief financial officer - Investing.com
[ARS] TENAX THERAPEUTICS, INC. SEC Filing - Stock Titan
Tenax Therapeutics (NASDAQ: TENX) 2026 proxy details director slate, auditor vote - Stock Titan
Tenax Therapeutics (NASDAQ: TENX) hires new CFO Thomas Staab with equity grants - Stock Titan
Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer - The Manila Times
Tenax Therapeutics, Inc. Announces Chief Financial Officer Changes - marketscreener.com
TENX SEC FilingsTenax Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Tenax Therapeutics (TENX) Stock Index Trade (Ticks Lower) 2026-04-20Retail Flow - Cổng thông tin điện tử Tỉnh Sơn La
Behavioral Patterns of TENX and Institutional Flows - Stock Traders Daily
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Panic Selling: Is Tenax Therapeutics Inc forming a double bottom2026 Institutional & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Is Tenax Therapeutics (TENX) Stock Priced Correctly | Price at $14.27, Down 1.11%Watchlist - Newser
CEO Moves: Is Tenax Therapeutics Inc forming a double bottom2026 Market Overview & Short-Term Trading Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX) and Ligand Pharma (LGND) - The Globe and Mail
If You Invested $1,000 in Tenax Therapeutics Inc (TENX) - Stock Titan
TENX Options Volatility — NASDAQ:TENX - TradingView
TENX Options Chain — NASDAQ:TENX - TradingView
TENAX Therapeutics (NASDAQ: TENX) — Morgan Stanley reports 3.5%/3.4% positions - Stock Titan
[SCHEDULE 13G/A] TENAX THERAPEUTICS, INC. Amended Passive Investment Disclosure - Stock Titan
Tenax Therapeutics, Inc. (NASDAQ:TENX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Is Tenax Therapeutics (TENX) Stock Suitable for 2026 | Price at $14.59, Down 1.95%Upside Potential - UBND thành phố Hải Phòng
(TENX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
TENX Should I Buy - Intellectia AI
[EFFECT] TENAX THERAPEUTICS, INC. SEC Filing - Stock Titan
Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat
Volume Summary: What are Tenax Therapeutics Incs recent SEC filings showingOil Prices & Daily Stock Trend Watchlist - baoquankhu1.vn
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
How (TENX) Movements Inform Risk Allocation Models - Stock Traders Daily
Tenax Therapeutics may offer up to $300 million of securities - marketscreener.com
Tenax Therapeutics May Offer Up To $300 Million Of Securities - TradingView — Track All Markets
Tenax Therapeutics (NASDAQ: TENX) registers $300M shelf to sell securities - Stock Titan
Tenax Therapeutics Inc (TENX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):